GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,671.80p
   
  • Change Today:
    -11.80p
  • 52 Week High: 1,846.00p
  • 52 Week Low: 1,374.60p
  • Currency: UK Pounds
  • Shares Issued: 5,017m
  • Volume: 15,040,090
  • Market Cap: £83,876m
  • RiskGrade: 167

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (29-05-2020)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.8% 4.8%
Div Cover 1.5 1.5
Op Mrgn 20.6% 23.9%
ROCE 59.5%  
Latest F'cast
P/E 13.5 14.3
PEG 3.6 n/a
Pr/Revenue 2.5 2.4
Pr/Book 4.6  
Latest F'cast
Revenue 9.5% 4.7%
PBT 29.6% 35.9%
EPS 3.8% -6.2%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 35,325.96 8,453.11 116.17p 14.4 n/a -6% 80.00p 4.8%
31-Dec-21 36,389.80 8,818.87 118.30p 14.1 7.7 +2% 80.07p 4.8%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Second Price Monitoring Extn 29-May-2020 16:41 RNS
Price Monitoring Extension 29-May-2020 16:37 RNS
Block listing Interim Review 26-May-2020 11:53 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
12-May-20 Transfer From Emma Walmsley 0.000p 7 £0.00
12-May-20 Buy Emma Walmsley 1,692.88p 7 £118.50
29-Apr-20 Buy Urs Rohner 1,693.00p 609 £10,310.37

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,671.80p
Change Today -11.80p
% Change -0.70 %
52 Week High 1,846.00p
52 Week Low 1,374.60p
Volume 15,040,090
Shares Issued 5,017m
Market Cap £83,876m
RiskGrade 167

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.42% below the market average59.42% below the market average59.42% below the market average59.42% below the market average59.42% below the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Price Trend
65.87% above the market average65.87% above the market average65.87% above the market average65.87% above the market average65.87% above the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average
Income
56.64% above the market average56.64% above the market average56.64% above the market average56.64% above the market average56.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
30.50% above the market average30.50% above the market average30.50% above the market average30.50% above the market average30.50% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 11
Sell 0
Strong Sell 3
Total 22
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 14-May-20 20-Feb-20
Paid 09-Jul-20 09-Apr-20
Amount 19.00p 23.00p

Trades for 29-May-2020

Time Volume / Share Price
17:03 100,000 @ 1,672.80p
16:45 9,716,566 @ 1,671.80p
16:30 300 @ 1,652.89p
16:29 71 @ 1,653.20p
16:29 229 @ 1,652.60p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page